期刊文献+

基因疫苗pcDNA-AChR_(α211)免疫小鼠建立重症肌无力动物模型 被引量:6

Construction of a myasthenia gravis model by immunizing mice with gene vaccine pcDNA-AChR_(α211)
下载PDF
导出
摘要 目的:用基因疫苗pcDNA-AChR_(α211)免疫C57BL/6小鼠建立实验性自身免疫性重症肌无力模型(EAMG)。方法:将人乙酰胆碱受体α亚基N端的主要免疫区(AChR_(α211))的基因片段插入到穿梭载体pcDNA3.0中,构建基因疫苗pcDNA-AChR_(α211)。大量提纯质粒pcDNA-AChR_(α211)后肌肉注射C57BL/6小鼠。用ELISA法检测小鼠血清中抗AChR_(α211)的IgG(ACh-RAb),并用PCR方法检测外源基因在小鼠各组织器官中的分布情况。结果:双酶切鉴定和序列测定表明构建了含正确目的基因阅读框的重组质粒pcDNA-AChR_(α211),ELISA分析表明该基因疫苗免疫的C57BL/6小鼠血清中含有AChRAb,且免疫三个月后在小鼠的肌肉、肝、脾、肾中仍可检测到目的基因AChR_(α211)的存在。结论:重组质粒pcDNA-AChR_(α211)作为基因疫苗能够诱导实验性自身免疫性重症肌无力。 Objective:To establish an experimental autoimmune myasthenia gravis by immunizing C57BL/6 mice with gene vaccine of pcDNA-AChRα211 Methods:pcDNA-AChRα211 was constructed by inserting the gene fragment of human acetylcholine receptor α-subunit N-terminal 211 residues( AChRα211 ) into shuttle plasmid pcDNA3.0. Then the gene vaccine was directly injected intramuscularly into C57BL/6 mice. The AChRAb in serum of immunized mice were tested by ELISA. The AChRα211 DNA fragment was reamplified by PCR with total DNA of mouse tissues as the template. Results:The recombinant plasmid pcDNA-AChRα211 was testified by double enzymatic digestion to confirm the inserted site. DNA sequence analysis showed that the open reading frame of the inserted gene was the same as the original one. After immunization, the corresponding antibody, AChRAb, was detected in mice sera. The target gene could be re-amplified by PCR in muscle, liver, spleen and kidney of immunized mice. Conclusion:pcDNA-AChRα211 as gene vaccine could induce experimental autoimmune myasthenia gravis.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第3期216-219,共4页 Chinese Journal of Immunology
基金 本文为国家自然科学基金项目(30270292)
关键词 基因疫苗 PCDNA3.0 AChRα211 体液免疫应答 Gene vaccine pcDNA3.0 AChRα211 Humoral immunity response
  • 相关文献

参考文献8

  • 1Graus Y M,De Baets M H.Myasthenia gravis:an autoimmune response against the acetylcholine receptor[J].Immunol Res,1993; 12 (1):78-100.
  • 2Christadoss P,Poussin M,Deng C et al.Animal models of myasthenia gravis[J].Clin Immunol,2000; 94(2):75-87.
  • 3黄培堂.分子克隆实验指南[M].第3版.北京:科学出版社,2002:17-25.
  • 4Lennon V A,Lindstrom J M,Seybold M E.Experimental autoimmune myasthenia gravis:cellular and humoral immune responses[J].Ann N Y Acad Sci,1976; 274:283-299.
  • 5Lewis P J,Babiuk L A.DNA vaccines:a review[J].Adv Viru Res,1999; 54:129-188.
  • 6Lindstrom J,Einarson B.Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis[J].Muscle Nerve,1979;2(3):173-179.
  • 7Walff J A,Malone R W,Williams P et al.Direct gene transfer into mouse muscle in vivo[J].Science,1990;247:1465-1468.
  • 8宋勤叶,杨汉春.核酸疫苗研究进展[J].动物医学进展,2004,25(3):37-40. 被引量:12

二级参考文献21

  • 1[1]Yokoyama M,Hassett D E,Zhang J,et al.DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site[J].Vaccine,1997,15: 553-560.
  • 2[2]Davis H L,Millan C L,Watkins S C.Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA[J].Gene Ther,1997,(4):181-188.
  • 3[3]Torres C A,Iwasaki A, Barber B H,et al.Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations[J].J Immunol, 1997, 158: 4529-4532.
  • 4[4]Fu T M,Ulmer J B,Caulfield M J,et al.Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes[J].Mol Med,1997,(3):362-371.
  • 5[5]Whitton J L,Rodriguez F, Zhang J, et al.DNA immunization: mechanistic studies[J].Vaccine,1999,17:1612-1619.
  • 6[6]Iwasaki A, Torres C A T,Ohashi P S,et al.The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites[J].J Immunol, 1997, 159: 11-14.
  • 7[8]Heinen P P,Rijsewijk F A,de Boer-Luijtze E A,et al.Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus[J].J General Virol,2002,83:1851-1859.
  • 8[9]Heckert R A,Elankumaran S,Oshop G L,et al.A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization[J].2002,89:67-81.
  • 9[10]Hess J,Gentschev I, Milo D, et al.Superior efficacy of secreted over somatic antigen display in recombinant salmonella vaccine induced protection against listeriosis[J].Proc Natl Acad Sci USA, 1996, 93: 1458-1463.
  • 10[11]Khan S A,Stratford R, Wu T, et al.Salmonella typhi and S.typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors[J].Vaccine, 2003,21:539-548.

共引文献12

同被引文献70

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部